Dr. Marcus Chen7 min read
The GLP-1 Revolution
Glucagon-like peptide-1 (GLP-1) receptor agonists have transformed metabolic research. Originally studied for glucose homeostasis, these peptides have revealed far-reaching effects on appetite regulation, cardiovascular health, and body composition.
Key Compounds
Semaglutide A GLP-1 receptor agonist with 94% homology to native GLP-1. Its albumin-binding modification extends its half-life to approximately 7 days, making it ideal for weekly dosing studies.
Tirzepatide The first dual GIP/GLP-1 receptor agonist, representing a paradigm shift in metabolic peptide research. By activating both incretin receptors, it provides researchers with a unique tool to study combined pathway effects.
Research Applications
- Glucose homeostasis mechanisms
- Appetite regulation pathways
- Cardiovascular effects of metabolic peptides
- Body composition changes
- Neuroprotective effects of GLP-1 signaling
- Hepatic steatosis research
Emerging Research Directions
The field continues to evolve with oral formulations, triple agonists (GLP-1/GIP/glucagon), and combination therapies opening new research avenues.